HomeInsights52 Week Low Stocks

Natco Pharma Ltd 52 Week Low

Natco Pharma Ltd 52 Week Low

stocks purchased

₹ 4.1 Cr

Volume transacted

stocks purchased

26.5 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Natco Pharma Ltd

NSE: NATCOPHARM

YEARLOW

725

Last updated: 18 Sep 24

Key Highlights

  • The 52 Week Low of Natco Pharma Ltd is ₹ 725 as of 18 Sep 24.

Company Fundamentals for Natco Pharma Ltd

No data available

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 20241540.25
17 Sep 20241561.55
16 Sep 20241577
13 Sep 20241582.9
12 Sep 20241592.6
11 Sep 20241592
10 Sep 20241545.5
09 Sep 20241545.75
06 Sep 20241560
05 Sep 20241554.2

Asset Value vs Market Value of Natco Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Natco Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Natco Pharma Ltd

No data available

* All values are in crore

Natco Pharma Ltd News Hub

News

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis

Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) In...

Read more

04 Sep 202412:07

News

Natco Pharma Canada arm invests $8 mln in eGenesis

eGenesis is engaged in using its multiplex gene editing and genome engineering platform to...

Read more

04 Sep 202412:01

News

Natco Pharma Ltd spurts 1.25%, up for third straight session

Natco Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 1570....

Read more

23 Aug 202413:05

News

Natco Pharma schedules AGM

Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be h...

Read more

12 Aug 202416:48

News

Board of Natco Pharma recommends dividend

Natco Pharma announced that the Board of Directors of the Company at its meeting held on 1...

Read more

12 Aug 202415:57

News

Natco Pharma spurts as Q1 PAT climbs 59% YoY to Rs 668 cr

Revenue from operations was at Rs 1,362.6 crore in Q1 FY25, up 19.47% from Rs 1140.5 crore...

Read more

12 Aug 202415:13

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Natco Pharma Ltd

Why is it important to track the 52-week low of Natco Pharma Ltd stocks?

Investors should monitor the 52-week low of Natco Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Natco Pharma Ltd stocks hitting a 52-week low?

Factors leading to Natco Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Natco Pharma Ltd stocks when they hit a 52-week low?

Buying Natco Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Natco Pharma Ltd stocks?

Investors should monitor the 52-week low of Natco Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Natco Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Natco Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Natco Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Natco Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Natco Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*